Dr. Frank Diana is experienced in the areas of CMC, Pharmaceutical and Analytical Development. Dr. Diana had a 40-year career in the Pharmaceutical Industry working for Endo Pharmaceuticals, Johnson & Johnson and DuPont Pharmaceuticals mostly in Pharmaceutical Development, Technical Operations and Quality. He obtained his PhD from St. John’s University in NY and is an adjunct professor in the RA/QA graduate program at Temple University’s School of Pharmacy teaching several courses including Global CMC Issues.
Current role
Head of CMC Regulatory Affairs at TILT Biotherapeutics
SVP, CMC & Regulatory at Ora
VP, CMC & Regulatory Affairs at Stayble Therapeutics
SVP, Quality & CMC Regulatory Affairs at ReCode Therapeutics
Associate Director CMC Regulatory Affairs at ISA Pharmaceuticals